France spent €33 billion on medicines in 2007
This article was originally published in Scrip
French statisticians have reached a final tally of €33.4 billion spent on medicines in 2007, an increase of 4.4% on the year before. The DREES report on the cost of national healthcare takes all public and private spending in France into account, both in hospitals and in the community, rather than what is paid out in reimbursements through the social security system (Scrip Online, August 14th, 2008).
You may also be interested in...
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.